Matthew T Rondina

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. pmc Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients
    Matthew T Rondina
    Department of Internal Medicine, University of Utah, Salt Lake City, Utah 84132, USA
    Thromb Res 125:220-3. 2010
  2. pmc Whole blood flow cytometry measurements of in vivo platelet activation in critically-Ill patients are influenced by variability in blood sampling techniques
    Matthew T Rondina
    Divisions of General Internal Medicine, Department of Internal Medicine, Program in Molecular Medicine University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
    Thromb Res 129:729-35. 2012
  3. pmc In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1)
    Matthew T Rondina
    Division of General Internal Medicine, University of Utah, Salt Lake City, UT 84132, USA
    Chest 141:1490-5. 2012
  4. pmc A pilot study utilizing whole body 18 F-FDG-PET/CT as a comprehensive screening strategy for occult malignancy in patients with unprovoked venous thromboembolism
    Matthew T Rondina
    Division of General Internal Medicine, University of Utah, Salt Lake City, Utah 84132, USA
    Thromb Res 129:22-7. 2012
  5. pmc Drug-induced thrombocytopenia for the hospitalist physician with a focus on heparin-induced thrombocytopenia
    Matthew T Rondina
    Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT 84112, USA
    Hosp Pract (1995) 38:19-28. 2010
  6. pmc Soluble CD40 ligand as a predictor of coronary artery disease and long-term clinical outcomes in stable patients undergoing coronary angiography
    Matthew T Rondina
    Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
    Cardiology 109:196-201. 2008
  7. ncbi request reprint The accuracy of activated partial thromboplastin times when drawn through a peripherally inserted central catheter
    Matthew T Rondina
    Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
    Am J Hematol 82:738-9. 2007
  8. ncbi request reprint The treatment of venous thromboembolism in special populations
    Matthew T Rondina
    The University of Utah Health Sciences Center, Department of Internal Medicine, Salt Lake City, UT 84132, USA
    Thromb Res 119:391-402. 2007
  9. pmc Abdominal aortitis due to Streptococcus pneumoniae and Enterobacter aerogenes: a case report and review
    Matthew T Rondina
    Department of Internal Medicine, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    J Gen Intern Med 21:C1-3. 2006
  10. pmc The septic milieu triggers expression of spliced tissue factor mRNA in human platelets
    M T Rondina
    Division of General Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT 84132, USA
    J Thromb Haemost 9:748-58. 2011

Collaborators

Detail Information

Publications27

  1. pmc Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients
    Matthew T Rondina
    Department of Internal Medicine, University of Utah, Salt Lake City, Utah 84132, USA
    Thromb Res 125:220-3. 2010
    ....
  2. pmc Whole blood flow cytometry measurements of in vivo platelet activation in critically-Ill patients are influenced by variability in blood sampling techniques
    Matthew T Rondina
    Divisions of General Internal Medicine, Department of Internal Medicine, Program in Molecular Medicine University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
    Thromb Res 129:729-35. 2012
    ..Flow cytometry is often used to measure in vivo platelet activation in critically-ill patients. Variability in blood sampling techniques, which may confound these measurements, remains poorly characterized...
  3. pmc In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1)
    Matthew T Rondina
    Division of General Internal Medicine, University of Utah, Salt Lake City, UT 84132, USA
    Chest 141:1490-5. 2012
    ..Changes in platelet reactivity during 2009 influenza A(H1N1) (A[H1N1]) have not been characterized...
  4. pmc A pilot study utilizing whole body 18 F-FDG-PET/CT as a comprehensive screening strategy for occult malignancy in patients with unprovoked venous thromboembolism
    Matthew T Rondina
    Division of General Internal Medicine, University of Utah, Salt Lake City, Utah 84132, USA
    Thromb Res 129:22-7. 2012
    ..In a pilot study, we prospectively investigated the use of FDG-PET/CT to screen for occult malignancy in 40 patients with unprovoked VTE...
  5. pmc Drug-induced thrombocytopenia for the hospitalist physician with a focus on heparin-induced thrombocytopenia
    Matthew T Rondina
    Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT 84112, USA
    Hosp Pract (1995) 38:19-28. 2010
    ..Because patients with HIT have a high risk of thrombosis and bleeding is uncommon, the prompt initiation of an alternative anticoagulant (e.g., a direct thrombin inhibitor) is warranted in these patients...
  6. pmc Soluble CD40 ligand as a predictor of coronary artery disease and long-term clinical outcomes in stable patients undergoing coronary angiography
    Matthew T Rondina
    Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
    Cardiology 109:196-201. 2008
    ..We evaluated sCD40L levels and future cardiovascular events in patients not experiencing ACS...
  7. ncbi request reprint The accuracy of activated partial thromboplastin times when drawn through a peripherally inserted central catheter
    Matthew T Rondina
    Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
    Am J Hematol 82:738-9. 2007
    ..There were no clinically significant differences between aPTT values from the two samples. Using the PICC to obtain blood for the measurement of aPTT is accurate and may reduce the need for peripheral VPs...
  8. ncbi request reprint The treatment of venous thromboembolism in special populations
    Matthew T Rondina
    The University of Utah Health Sciences Center, Department of Internal Medicine, Salt Lake City, UT 84132, USA
    Thromb Res 119:391-402. 2007
    ..This review summarizes the current data for these special patient populations with venous thromboembolism and provides our recommendations for management...
  9. pmc Abdominal aortitis due to Streptococcus pneumoniae and Enterobacter aerogenes: a case report and review
    Matthew T Rondina
    Department of Internal Medicine, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    J Gen Intern Med 21:C1-3. 2006
    ..Clinicians should maintain a high index of suspicion for infectious aortitis as the mortality, if only treated medically, approaches 100%...
  10. pmc The septic milieu triggers expression of spliced tissue factor mRNA in human platelets
    M T Rondina
    Division of General Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT 84132, USA
    J Thromb Haemost 9:748-58. 2011
    ..A novel pathway involves splicing of pre-mRNAs in resting platelets to mature, translatable mRNAs in response to cellular activation...
  11. pmc Methicillin-resistant Staphylococcus aureus-induced thrombo-inflammatory response is reduced with timely antibiotic administration
    Zechariah Franks
    University of Utah, Department of Internal Medicine, 50 North Medical Drive, Room 4B120, SLC, Utah 84132, USA
    Thromb Haemost 109:684-95. 2013
    ..These data provide novel mechanistic evidence of the importance of prompt antibiotic administration in infectious syndromes...
  12. pmc (18)F-FDG PET in the evaluation of acuity of deep vein thrombosis
    Matthew T Rondina
    Division of General Internal Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84132, USA
    Clin Nucl Med 37:1139-45. 2012
    ..F-FDG PET has been used for vascular disease, but its role in deep vein thrombosis (DVT) remains prospectively unexplored...
  13. pmc Prospective comparison of three enoxaparin dosing regimens to achieve target anti-factor Xa levels in hospitalized, medically ill patients with extreme obesity
    Andrew Freeman
    Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA
    Am J Hematol 87:740-3. 2012
    ..5 mg/kg QDay is superior to FD and LD enoxaparin for the achievement of target anti-Factor Xa levels...
  14. pmc Platelets as cellular effectors of inflammation in vascular diseases
    Matthew T Rondina
    Department of Medicine and Program in Molecular Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA
    Circ Res 112:1506-19. 2013
    ..Recently identified inflammatory and immune activities provide insights into the biology of these versatile blood cells that are directly relevant to human vascular diseases...
  15. pmc Argatroban dose reductions for suspected heparin-induced thrombocytopenia complicated by child-pugh class C liver disease
    Peter M Yarbrough
    Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA
    Ann Pharmacother 46:e30. 2012
    ....
  16. pmc Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation
    Sara R Vazquez
    University of Utah Thrombosis Service, University of Utah, Department of Pharmacy Services, 675 Arapeen Drive, Suite 100, Salt Lake City, UT 84108, USA
    Thromb Res 126:e69-77. 2010
    ..In accordance with national guidelines, warfarin should be continued post-ablation for a minimum of 2 months and then indefinitely in patients with a CHADS(2) score >or= 2...
  17. pmc Bacteria differentially induce degradation of Bcl-xL, a survival protein, by human platelets
    Bjoern F Kraemer
    The Molecular Medicine Program, University of Utah, Salt Lake City, UT 84112, USA
    Blood 120:5014-20. 2012
    ....
  18. pmc Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets
    Hansjorg Schwertz
    Department of Internal Medicine, University of Utah, Salt Lake City, UT 84112, USA
    J Exp Med 203:2433-40. 2006
    ..We propose that platelet-derived TF contributes to the propagation and stabilization of a thrombus...
  19. pmc Carvedilol increases blood pressure response to phenylephrine infusion in heart failure subjects with systolic dysfunction: evidence of improved vascular alpha1-adrenoreceptor signal transduction
    Benjamin W Van Tassell
    Department of Pharmacotherapy, University of Utah, Salt Lake City, UT 84112, USA
    Am Heart J 156:315-21. 2008
    ..We examined alpha(1)-AR signal transduction by repeat phenylephrine (PE) infusions in patients with HF receiving chronic carvedilol therapy...
  20. pmc Initial fractal exponent of heart rate variability is associated with success of early resuscitation in patients with severe sepsis or septic shock: a prospective cohort study
    Samuel M Brown
    Pulmonary and Critical Care Medicine, Intermountain Medical Center, Murray, UT Pulmonary and Critical Care Medicine, University of Utah School of Medicine, Salt Lake City, UT Electronic address
    J Crit Care 28:959-63. 2013
    ..We hypothesized that loss of complexity in HRV upon intensive care unit (ICU) admission would be associated with unsuccessful early resuscitation of sepsis...
  21. pmc Alterations in platelet function during aging: clinical correlations with thromboinflammatory disease in older adults
    Donya Mohebali
    Divisions of General Internal Medicine, Department of Internal Medicine, Health Sciences Center, University of Utah, Salt Lake City, Utah
    J Am Geriatr Soc 62:529-35. 2014
    ..Established and developing antiplatelet therapies for the treatment of thrombotic and inflammatory disorders are also discussed in light of these data. ..
  22. pmc Platelet-leukocyte interactions link inflammatory and thromboembolic events in ischemic stroke
    Zechariah G Franks
    Program in Molecular Medicine, University of Utah, Salt Lake City, Utah, USA
    Ann N Y Acad Sci 1207:11-7. 2010
    ..In addition to mitigating thrombosis, antiplatelet drugs have direct and indirect effects on inflammation, which may translate to enhanced clinical efficacy...
  23. pmc Azathioprine-induced warfarin resistance
    Sara R Vazquez
    UDepartment of Pharmacy Services, University Thrombosis Service, University of Utah, Salt Lake City, UT 84108, USA
    Ann Pharmacother 42:1118-23. 2008
    ..To describe a case of azathioprine-induced warfarin resistance, present a literature review on warfarin-azathioprine interactions, and provide recommendations on appropriate management of this clinically significant interaction...
  24. pmc Prevention of venous thromboembolism in obesity
    Andrew L Freeman
    University of Utah Department of Internal Medicine, 50 North Medical Drive, Room 4B120, School of Medicine, Salt Lake City, UT 84132, USA
    Expert Rev Cardiovasc Ther 8:1711-21. 2010
    ..With the prevalence of morbid obesity continuing to rise, more high-quality clinical data are needed to better understand the pathobiology of VTE in obesity and provide effective, yet safe, prevention strategies...
  25. pmc Contemporary issues in the prevention and management of postthrombotic syndrome
    Sara R Vazquez
    University of Utah Thrombosis Service, Department of Pharmacy Services, University of Utah, Salt Lake City, UT, USA
    Ann Pharmacother 43:1824-35. 2009
    ..To provide an evidence-based review and clinical summary of postthrombotic syndrome (PTS)...
  26. pmc Mammalian target of rapamycin regulates neutrophil extracellular trap formation via induction of hypoxia-inducible factor 1 α
    Alison M McInturff
    Department of Pediatrics Neonatology, University of Utah, Salt Lake City, UT 84108, USA
    Blood 120:3118-25. 2012
    ..Our studies define a pathway to NET formation involving 2 master regulators of immune cell function and identify potential points of molecular intervention in strategies to modify NETs in disease...
  27. ncbi request reprint Achieving National Cholesterol Education Program goals in coronary artery disease
    Matthew T Rondina
    The Heart Center, 1160 East 3900 South, Suite 2000, Salt Lake City, UT 84124, USA
    Prev Cardiol 8:18-22. 2005
    ..We concluded that the majority of CAD patients have had recent lipid measurements and are treated according to NCEP guidelines, but many patients remain on suboptimal therapy...